Physician profile
Jerome B Gardner
NPI 1811978067
$98,598.10
in general payments reported to CMS, 2019-2025
35 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,956 · 2020: $3,206 · 2021: $9,576 · 2022: $35K · 2023: $25K · 2024: $17K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $40K · Travel and Lodging: $1,055 · Food and Beverage: $487.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $39,779.28 |
| Travel and Lodging | $1,054.58 |
| Food and Beverage | $487.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $83,029.92 | 2021-2024 | Nexplanon |
| Merck Sharp & Dohme LLC | $13,412.16 | 2019-2021 | |
| Daiichi Sankyo INC. | $259.59 | 2019-2021 | |
| Therapeuticsmd, INC. | $223.36 | 2019-2021 | |
| Amgen INC. | $203.43 | 2019-2021 | |
| Abbvie INC. | $200.86 | 2019-2022 | |
| Pfizer INC. | $178.30 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $144.23 | 2019-2022 | |
| Evofem Biosciences, INC. | $139.30 | 2021-2022 | |
| Avion Pharmaceuticals | $136.98 | 2019-2022 | |
| Baxter Healthcare | $53.78 | 2021-2022 | |
| Amag Pharmaceuticals, INC. | $50.54 | 2019-2020 | |
| Mayne Pharma Commercial LLC | $49.56 | 2021-2022 | |
| Vertical Pharmaceuticals, LLC | $49.14 | 2019 | |
| Mylan Pharmaceuticals INC. | $46.38 | 2019-2021 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $43.99 | 2019-2021 | |
| Exeltis, USA INC. | $43.18 | 2020-2021 | |
| Biohaven Pharmaceuticals, INC. | $38.53 | 2020-2021 | |
| Duchesnay USA Incorporated | $30.82 | 2019 | |
| Ethicon US, LLC | $29.47 | 2019 | |
| Astellas Pharma US INC | $28.91 | 2019-2020 | |
| Myovant Sciences INC. | $22.78 | 2022 | |
| Millicent US INC | $22.11 | 2021 | |
| Sage Therapeutics, LLC | $21.67 | 2021 | |
| Agile Therapeutics, INC. | $19.30 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $17.15 | 2022 | |
| Allergan, INC. | $16.51 | 2020 | |
| Bausch Health US, LLC | $15.30 | 2020 | |
| Glaxosmithkline, LLC. | $14.83 | 2020 | |
| Medicem INC. | $14.54 | 2020 | |
| Hologic Sales and Service, LLC | $14.16 | 2019 | |
| Urovant Sciences INC | $13.97 | 2021 | |
| Lupin INC. | $13.35 | 2020 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$5.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jerome Gardner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.